164 related articles for article (PubMed ID: 7507741)
1. Antiproliferative effects and DNA hypomethylation by 5-aza-2'-deoxycytidine in human neuroblastoma cell lines.
Carpinelli P; Granata F; Augusti-Tocco G; Rossi M; Bartolucci S
Anticancer Drugs; 1993 Dec; 4(6):629-35. PubMed ID: 7507741
[TBL] [Abstract][Full Text] [Related]
2. Effect of cytidine analogs on cell growth and differentiation on a human neuroblastoma line.
Bartolucci S; Estenoz M; de Franciscis V; Carpinelli P; Colucci GL; Augusti Tocco G; Rossi M
Cell Biophys; 1989; 15(1-2):67-77. PubMed ID: 2476228
[TBL] [Abstract][Full Text] [Related]
3. 5-Aza-2'-deoxycytidine as inducer of differentiation and growth inhibition in mouse neuroblastoma cells.
Bartolucci S; Estenoz M; Longo A; Santoro B; Momparler RL; Rossi M; Augusti-Tocco G
Cell Differ Dev; 1989 Jun; 27(1):47-55. PubMed ID: 2475229
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological approach for optimization of the dose schedule of 5-Aza-2'-deoxycytidine (Decitabine) for the therapy of leukemia.
Momparler RL; Côté S; Eliopoulos N
Leukemia; 1997 Feb; 11(2):175-80. PubMed ID: 9009076
[TBL] [Abstract][Full Text] [Related]
5. Induction of cytidine deaminase in HL-60 myeloid leukemic cells by 5-aza-2'-deoxycytidine.
Momparler RL; Laliberté J
Leuk Res; 1990; 14(9):751-4. PubMed ID: 1700230
[TBL] [Abstract][Full Text] [Related]
6. Comparison of antineoplastic activity of cytosine arabinoside and 5-aza-2'-deoxycytidine against human leukemic cells of different phenotype.
Momparler RL; Onetto-Pothier N; Momparler LF
Leuk Res; 1990; 14(9):755-60. PubMed ID: 1700231
[TBL] [Abstract][Full Text] [Related]
7. Studies on the mechanism of the synergistic interaction between 2'-deoxy-5-azacytidine and cisplatin.
Abbruzzese JL; Frost P
Cancer Chemother Pharmacol; 1992; 30(1):31-6. PubMed ID: 1375133
[TBL] [Abstract][Full Text] [Related]
8. The effect of 5-azacytidine (5-aza-CR) and its analogue on cell differentiation and DNA methylation of HL-60 cells.
He ZX; Rao H
Sci China B; 1993 Apr; 36(4):430-8. PubMed ID: 7691071
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of DNA methylation by 5-aza-2'-deoxycytidine suppresses the growth of human tumor cell lines.
Bender CM; Pao MM; Jones PA
Cancer Res; 1998 Jan; 58(1):95-101. PubMed ID: 9426064
[TBL] [Abstract][Full Text] [Related]
10. Preclinical evaluation of antineoplastic activity of inhibitors of DNA methylation (5-aza-2'-deoxycytidine) and histone deacetylation (trichostatin A, depsipeptide) in combination against myeloid leukemic cells.
Shaker S; Bernstein M; Momparler LF; Momparler RL
Leuk Res; 2003 May; 27(5):437-44. PubMed ID: 12620295
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the antileukemic activity of 5-AZA-2'-deoxycytidine, 1-beta-D-arabinofuranosylcytosine and 5-azacytidine against L1210 leukemia.
Momparler RL; Momparler LF; Samson J
Leuk Res; 1984; 8(6):1043-9. PubMed ID: 6083417
[TBL] [Abstract][Full Text] [Related]
12. Effect of 5-azacytidine and congeners on DNA methylation and expression of deoxycytidine kinase in the human lymphoid cell lines CCRF/CEM/0 and CCRF/CEM/dCk-1.
Antonsson BE; Avramis VI; Nyce J; Holcenberg JS
Cancer Res; 1987 Jul; 47(14):3672-8. PubMed ID: 2439195
[TBL] [Abstract][Full Text] [Related]
13. 3-Deazauridine enhances the antileukemic action of 5-aza-2'-deoxycytidine and targets drug-resistance due to deficiency in deoxycytidine kinase.
Raynal NJ; Momparler LF; Rivard GE; Momparler RL
Leuk Res; 2011 Jan; 35(1):110-8. PubMed ID: 20510451
[TBL] [Abstract][Full Text] [Related]
14. Induction of differentiation and inhibition of DNA methylation in HL-60 myeloid leukemic cells by 5-AZA-2'-deoxycytidine.
Momparler RL; Bouchard J; Samson J
Leuk Res; 1985; 9(11):1361-6. PubMed ID: 2417065
[TBL] [Abstract][Full Text] [Related]
15. The Effect of 5-aza,2'-deoxyCytidine (5 AZA CdR or Decitabine) on Extrinsic, Intrinsic, and JAK/STAT Pathways in Neuroblastoma and Glioblastoma Cells Lines.
Sanaei M; Kavoosi F
Asian Pac J Cancer Prev; 2023 Jun; 24(6):1841-1854. PubMed ID: 37378911
[TBL] [Abstract][Full Text] [Related]
16. In vitro cytotoxic and biochemical effects of 5-aza-2'-deoxycytidine.
Momparler RL; Goodman J
Cancer Res; 1977 Jun; 37(6):1636-9. PubMed ID: 66984
[TBL] [Abstract][Full Text] [Related]
17. Effects of 5-aza-2'-deoxycytidine and interferon-alpha on differentiation and oncogene expression in HL-60 myeloid leukemic cells.
Doré BT; Momparler RL
Anticancer Drugs; 1992 Jun; 3(3):281-7. PubMed ID: 1381972
[TBL] [Abstract][Full Text] [Related]
18. Antineoplastic action of 5-aza-2'-deoxycytidine and phenylbutyrate on human lung carcinoma cells.
Boivin AJ; Momparler LF; Hurtubise A; Momparler RL
Anticancer Drugs; 2002 Sep; 13(8):869-74. PubMed ID: 12394273
[TBL] [Abstract][Full Text] [Related]
19. Activation of the p53 DNA damage response pathway after inhibition of DNA methyltransferase by 5-aza-2'-deoxycytidine.
Karpf AR; Moore BC; Ririe TO; Jones DA
Mol Pharmacol; 2001 Apr; 59(4):751-7. PubMed ID: 11259619
[TBL] [Abstract][Full Text] [Related]
20. 5-aza-2'-deoxycytidine therapy in patients with acute leukemia inhibits DNA methylation.
Momparler RL; Bouchard J; Onetto N; Rivard GE
Leuk Res; 1984; 8(2):181-5. PubMed ID: 6201685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]